Propylphenidine
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C17H21N |
| Molar mass | 239.362 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Propylphenidine is a compound which has been sold as a designer drug, first identified in Australia in 2023. It is unclear what kind of activity it has, as it is claimed to be a stimulant in a patent along with related compounds such as phenylpropylaminopentane, but other structurally similar compounds such as ephenidine and isophenidine are dissociative anesthetic drugs, so it may produce either kind of activity or perhaps a mixture of both.[1][2][3]
Legal Status
[edit]In Australia, the Therapeutic Goods Administration decided to include propylphenidine as a Prohibited substance (Schedule 9) within the Standard for the Uniform Scheduling of Medicines and Poisons alongside four other phenidine analogs on 1 October 2024.[4]
See also
[edit]References
[edit]- ^ US 5220068, Knoll J, Simay A, Szinnyei E, Somfai E, Torok Z, Mozsolits K, Bergmann J, "Psychostimulant agent", issued 15 June 1993, assigned to Chinoin Private Co Ltd
- ^ Morris H, Wallach J (July–August 2014). "From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs". Drug Testing and Analysis. 6 (7–8): 614–632. doi:10.1002/dta.1620. PMID 24678061.
- ^ Algar JL, Lawes DJ, Carroll AJ, Caldicott D, McLeod MD (January 2024). "Identification of three unexpected new psychoactive substances at an Australian drug checking service". Drug Testing and Analysis. 16 (10): 1144–1154. doi:10.1002/dta.3637. PMID 38205685.
- ^ "Notice of final decision to amend (or not amend) the current Poisons Standard - ACMS #44, ACCS #38, Joint ACMS-ACCS #36". Therapeutic Goods Administration. 27 September 2024. Retrieved 5 October 2025.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |